0.755
price down icon0.13%   -0.001
after-market Dopo l'orario di chiusura: .75 -0.005 -0.66%
loading
Precedente Chiudi:
$0.756
Aprire:
$0.7625
Volume 24 ore:
150.72K
Relative Volume:
0.05
Capitalizzazione di mercato:
$3.69M
Reddito:
$14.64M
Utile/perdita netta:
$-13.74M
Rapporto P/E:
-0.0721
EPS:
-10.47
Flusso di cassa netto:
$-5.04M
1 W Prestazione:
+16.01%
1M Prestazione:
+6.34%
6M Prestazione:
-77.27%
1 anno Prestazione:
-93.98%
Intervallo 1D:
Value
$0.7373
$0.774
Intervallo di 1 settimana:
Value
$0.606
$0.785
Portata 52W:
Value
$0.3611
$12.78

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
Nome
Novabay Pharmaceuticals Inc
Name
Telefono
510-899-8800
Name
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Name
Dipendente
86
Name
Cinguettio
@NovaBayPharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
NBY's Discussions on Twitter

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-09-18 Iniziato Ladenburg Thalmann Buy
2018-07-06 Reiterato H.C. Wainwright Buy
2017-11-15 Reiterato Laidlaw Buy
2017-06-05 Iniziato ROTH Capital Buy
2017-03-27 Iniziato Laidlaw Buy
2017-02-06 Iniziato Rodman & Renshaw Buy
2016-03-07 Downgrade Maxim Group Buy → Hold
2015-12-14 Reiterato Maxim Group Buy
2015-04-30 Ripresa Maxim Group Buy
2013-03-06 Iniziato Ascendiant Capital Markets Strong Buy
2008-01-03 Iniziato Dawson James Speculative Buy
Mostra tutto

Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie

pulisher
Nov 01, 2024

NovaBay Pharmaceuticals : Signs Distribution Agreement With the Biopharm Group - Marketscreener.com

Nov 01, 2024
pulisher
Oct 31, 2024

# NovaBay Pharmaceuticals Considers Acquisition Offer in Recent SEC Filing - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

NovaBay Pharmaceuticals receives unsolicited offer from Refresh Acquisitions - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC - StockTitan

Oct 29, 2024
pulisher
Sep 26, 2024

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell Its Avenova Assets - Vision Monday

Sep 26, 2024
pulisher
Sep 25, 2024

Novabay Pharmaceuticals Inc (NBY) Stock: A Year of Market Fluctuations - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

Before You Invest, Make Sure You Check This Novabay Pharmaceuticals Inc (AMEX: NBY) Analysis - Stocks Register

Sep 25, 2024
pulisher
Sep 25, 2024

Novabay Pharmaceuticals Inc (NBY)’s Market Momentum: Closing Strong at 0.70, Down -5.62 - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

NovaBay Pharmaceuticals, Inc. announced that it expects to receive $2.83 million in funding from Pioneer Pharma Pte. Ltd. and other investors. - Marketscreener.com

Sep 24, 2024
pulisher
Sep 24, 2024

A new trading data show Novabay Pharmaceuticals Inc (NBY) is showing positive returns. - SETE News

Sep 24, 2024
pulisher
Sep 22, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

What's Going On With NovaBay Pharmaceuticals Shares Friday? - Benzinga

Sep 20, 2024
pulisher
Sep 20, 2024

NBY’s price-to-free cash flow ratio: What it means for investors - US Post News

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay sells Avenova brand to PRN for $9.5 million - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

PRN Nutriceuticals agreed to acquire Assets of Avenova Brand and Business of NovaBay Pharmaceuticals, Inc.. - Marketscreener.com

Sep 20, 2024
pulisher
Sep 20, 2024

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay sells Avenova brand to PRN for $9.5 million By Investing.com - Investing.com South Africa

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay Pharma Announces Avenova Sale and Planned Dissolution - TipRanks

Sep 20, 2024
pulisher
Sep 20, 2024

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals - PR Newswire

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets - StockTitan

Sep 20, 2024
pulisher
Sep 06, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World

Sep 06, 2024
pulisher
Sep 02, 2024

Impetigo Drugs Global Strategic Business Report 2024 - GlobeNewswire Inc.

Sep 02, 2024
pulisher
Aug 20, 2024

Was there any good news for Novabay Pharmaceuticals Inc (NBY) stock in the last session? - US Post News

Aug 20, 2024
pulisher
Aug 19, 2024

Novabay Pharmaceuticals Inc Inc. (NBY) Price Performance: The Role of Supply and Demand - The InvestChronicle

Aug 19, 2024
pulisher
Aug 16, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Announces Quarterly Earnings Results - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 16, 2024
pulisher
Aug 15, 2024

Novabay Pharmaceuticals Inc (NBY)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Aug 15, 2024
pulisher
Aug 15, 2024

Earnings call: NovaBay Pharmaceuticals reports growth in eyecare By Investing.com - Investing.com Australia

Aug 15, 2024
pulisher
Aug 15, 2024

NovaBay Pharmaceuticals Reports Mixed Second Quarter 2024 Financial Results - Vision Monday

Aug 15, 2024
pulisher
Aug 14, 2024

Earnings call: NovaBay Pharmaceuticals reports growth in eyecare - Investing.com

Aug 14, 2024
pulisher
Aug 14, 2024

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Crosses Above 50-Day Moving Average of $0.00 - Defense World

Aug 14, 2024
pulisher
Aug 14, 2024

NovaBay To Hold 2017 Second Quarter Conference Call On August 10, 2017 - BioSpace

Aug 14, 2024
pulisher
Aug 13, 2024

NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 13, 2024

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results - wallstreet:online

Aug 13, 2024
pulisher
Aug 09, 2024

Ratio Analysis: Unpacking Novabay Pharmaceuticals Inc (NBY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Aug 09, 2024
pulisher
Aug 09, 2024

NBY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Aug 09, 2024
pulisher
Aug 07, 2024

NovaBay stock hits 52-week low at $0.47 amid steep annual decline - Investing.com

Aug 07, 2024
pulisher
Aug 02, 2024

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering - Vision Monday

Aug 02, 2024
pulisher
Aug 01, 2024

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 - StockTitan

Aug 01, 2024
pulisher
Jul 31, 2024

Adversity is less terrifying than hope: Novabay Pharmaceuticals Inc (NBY) - SETE News

Jul 31, 2024
pulisher
Jul 30, 2024

NovaBay reports surge in Avenova sales during Prime Day - Investing.com

Jul 30, 2024
pulisher
Jul 30, 2024

NovaBay reports surge in Avenova sales during Prime Day By Investing.com - Investing.com Canada

Jul 30, 2024
pulisher
Jul 30, 2024

NBYNovaBay Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Jul 30, 2024
pulisher
Jul 30, 2024

Novabay Pharmaceuticals Inc (NBY) shows promising results - US Post News

Jul 30, 2024
pulisher
Jul 30, 2024

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales - StockTitan

Jul 30, 2024
pulisher
Jul 30, 2024

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - American Banking and Market News

Jul 30, 2024
pulisher
Jul 29, 2024

What's Going On With NovaBay Pharmaceuticals (NBY) Stock? - Benzinga

Jul 29, 2024
pulisher
Jul 29, 2024

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option - StockTitan

Jul 29, 2024
pulisher
Jul 29, 2024

NBY’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Jul 29, 2024
pulisher
Jul 28, 2024

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Up 27.0% in July - Defense World

Jul 28, 2024
pulisher
Jul 26, 2024

NovaBay Pharmaceuticals (AMEX:NBY) Stock Quotes, Forecast and News Summary - Benzinga

Jul 26, 2024

Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):